|
Market Closed -
Nasdaq
16:00:00 2026-09-23 EDT
|
5-day change | 1st Jan Change | ||
| 8.020 USD | -10.09% |
|
-8.03% | +42.20% |
| 09-16 | Solid Biosciences' Duchenne Muscular Dystrophy Approach, FDA Shift Support Upside, RBC Says | MT |
| 09-16 | RBC Initiates Solid Biosciences at Outperform, Speculative Risk With $18 Price Target | MT |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| SLDB | Delayed | |
CBOE
| SLDB | Real-time |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Neutral | Bullish |
| Resistance | 9.08 | 11.15 | 10.84 |
| Spread/Res. | -11.67% | -28.07% | -26.01% |
| Spread/Supp. | +2.43% | +31.91% | +21.15% |
| Support | 7.83 | 6.08 | 6.62 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- SLDB Stock
- Charts Solid Biosciences Inc.
Select your edition
All financial news and data tailored to specific country editions
